BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32787688)

  • 1. Blockade of IL-6 alleviates bone loss induced by modeled microgravity in mice.
    He B; Yin X; Hao D; Zhang X; Zhang Z; Zhang K; Yang X
    Can J Physiol Pharmacol; 2020 Oct; 98(10):678-683. PubMed ID: 32787688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of hind-limb suspension-induced bone loss by curcumin is associated with reduced oxidative stress and increased vitamin D receptor expression.
    Xin M; Yang Y; Zhang D; Wang J; Chen S; Zhou D
    Osteoporos Int; 2015 Nov; 26(11):2665-76. PubMed ID: 25963235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hydrogen molecule abates oxidative stress and alleviates bone loss induced by modeled microgravity in rats.
    Sun Y; Shuang F; Chen DM; Zhou RB
    Osteoporos Int; 2013 Mar; 24(3):969-78. PubMed ID: 22648000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with hydrogen sulfide donor attenuates bone loss induced by modeled microgravity.
    Yang M; Zhang K; Zhang X; Zhang Z; Yin X; He G; Li L; Yang X; He B
    Can J Physiol Pharmacol; 2019 Jul; 97(7):655-660. PubMed ID: 30870598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with resveratrol attenuates sublesional bone loss in spinal cord-injured rats.
    Wang HD; Shi YM; Li L; Guo JD; Zhang YP; Hou SX
    Br J Pharmacol; 2013 Oct; 170(4):796-806. PubMed ID: 23848300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrolactin A protects against LPS-induced bone loss by regulation of bone remodeling.
    Sapkota M; Gao M; Li L; Yang M; Shrestha SK; Choi H; Soh Y
    Eur J Pharmacol; 2020 Sep; 883():173305. PubMed ID: 32673673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Icariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptor-dependent osteoblastic functions in UMR 106 cells.
    Mok SK; Chen WF; Lai WP; Leung PC; Wang XL; Yao XS; Wong MS
    Br J Pharmacol; 2010 Feb; 159(4):939-49. PubMed ID: 20128811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis.
    Ozaki Y; Koide M; Furuya Y; Ninomiya T; Yasuda H; Nakamura M; Kobayashi Y; Takahashi N; Yoshinari N; Udagawa N
    PLoS One; 2017; 12(9):e0184904. PubMed ID: 28937990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabidiol administration reduces sublesional cancellous bone loss in rats with severe spinal cord injury.
    Li D; Lin Z; Meng Q; Wang K; Wu J; Yan H
    Eur J Pharmacol; 2017 Aug; 809():13-19. PubMed ID: 28479140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a low-dose anti-resorptive drug regimen reveals synergistic suppression of bone formation when coupled with disuse.
    Lloyd SA; Travis ND; Lu T; Bateman TA
    J Appl Physiol (1985); 2008 Mar; 104(3):729-38. PubMed ID: 18174391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Osteoporotic Effect of Morroniside on Osteoblast and Osteoclast Differentiation In Vitro and Ovariectomized Mice In Vivo.
    Lee CG; Kim J; Yun SH; Hwang S; Jeon H; Park E; Jeong SY
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
    Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
    Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection by salidroside against bone loss via inhibition of oxidative stress and bone-resorbing mediators.
    Zhang JK; Yang L; Meng GL; Yuan Z; Fan J; Li D; Chen JZ; Shi TY; Hu HM; Wei BY; Luo ZJ; Liu J
    PLoS One; 2013; 8(2):e57251. PubMed ID: 23437352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AQP9: a novel target for bone loss induced by microgravity.
    Bu G; Shuang F; Wu Y; Ren D; Hou S
    Biochem Biophys Res Commun; 2012 Mar; 419(4):774-8. PubMed ID: 22390930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic role of hydroxyapatite nanoparticles and pulsed electromagnetic field therapy to prevent bone loss in rats following exposure to simulated microgravity.
    Prakash D; Behari J
    Int J Nanomedicine; 2009; 4():133-44. PubMed ID: 19774112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin improves bone microarchitecture in glucocorticoid-induced secondary osteoporosis mice through the activation of microRNA-365 via regulating MMP-9.
    Li G; Bu J; Zhu Y; Xiao X; Liang Z; Zhang R
    Int J Clin Exp Pathol; 2015; 8(12):15684-95. PubMed ID: 26884838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice.
    Iida-Klein A; Zhou H; Lu SS; Levine LR; Ducayen-Knowles M; Dempster DW; Nieves J; Lindsay R
    J Bone Miner Res; 2002 May; 17(5):808-16. PubMed ID: 12009011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Puerarin prevents bone loss in ovariectomized mice and inhibits osteoclast formation in vitro.
    Yuan SY; Sheng T; Liu LQ; Zhang YL; Liu XM; Ma T; Zheng H; Yan Y; Ishimi Y; Wang XX
    Chin J Nat Med; 2016 Apr; 14(4):265-269. PubMed ID: 27114313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cycloastragenol prevents age-related bone loss: Evidence in d-galactose-treated and aged rats.
    Yu Y; Wu J; Li J; Liu Y; Zheng X; Du M; Zhou L; Yang Y; Luo S; Hu W; Li L; Yao W; Liu Y
    Biomed Pharmacother; 2020 Aug; 128():110304. PubMed ID: 32497865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
    Cai X; Xing J; Long CL; Peng Q; Humphrey MB
    J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.